Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Solid Tumors × litronesib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 3 Stomach Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Blast Crisis 1

Interventions

Paclitaxel 11 atezolizumab 9 Gemcitabine 9 pembrolizumab 8 Carboplatin 6 Irinotecan 5 Injections 5 Docetaxel 5 Cetuximab 5 navitoclax 4 Leucovorin 4 Fluorouracil 4 olaparib 3 Oxaliplatin 3 Nivolumab 3 Bevacizumab 3 zolbetuximab 2 tocilizumab 2 tivozanib 2 tislelizumab 2 spartalizumab 2 ridaforolimus 2 plocabulin 2 liposomal doxorubicin 2 linifanib 2 lenvatinib 2 ipatasertib 2 envafolimab 2 cobimetinib 2 brigimadlin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01358019 2013-01-28

2523355-001

Kyowa Kirin Co., Ltd.

Phase 1 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡